Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹Ankara Üniversitesi Tıp Fakültesi Göz Hastalıkları, A.D., Ankara, Prof. Dr.
²Ankara Üniversitesi Tıp Fakültesi Göz Hastalıkları, A.D., Ankara, Uzm. Dr. Intravitreal bevacizumab was injected in a patient with neovascular glaucoma due to central retinal vein occlusion in order to decrease vascular leakage from iris vessels. A 46 -year-old man with central retinal vein occlusion in the right eye presented with neovascularization of the iris and intraocular pressure (IOP) of 46 mmHg. Retinal photocoagulation could not be continued because of corneal edema related to high IOP causing decreased fundus visualization. Morphologic changes and vascular leakage were evaluated before and after intravitreal injection by iris fluorescein angiography. Decrease in leakage was detected as early as 2 day -one week after injection. No inflammation or relapse was seen within the follow-up of 1-4 weeks. Intravitreal bevacizumab injection may be a useful alternative treatment for patients with neovascular glaucoma in whom inadequate visualization precludes treatment with retinal photocoagulation . Additionally it may be used as an adjunct before glaucoma or vitreoretinal surgery Keywords : intravitreal bevacizumab, neovascular glaucoma, iris neovascularisation